|Articles|January 22, 2021
Analysis of Risk-Based Quality Management Approach
Author(s)Covance
This white paper investigates best practices and tangible benefits associated with a risk-based quality management (RBQM) approach to clinical trial management.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
4
Optimizing Kinetics Assays to Avoid Avidity Effects
5